Vaxil Bio Ltd (VXLLF)
0.005
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
Vaxil Bio 1 Year Total Returns (Daily): -58.33% for May 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 01, 2024 | -58.33% |
April 30, 2024 | -65.99% |
April 29, 2024 | -65.99% |
April 26, 2024 | -58.33% |
April 25, 2024 | -58.33% |
April 24, 2024 | -64.43% |
April 23, 2024 | -66.44% |
April 22, 2024 | -64.43% |
April 19, 2024 | -64.43% |
April 18, 2024 | -64.43% |
April 17, 2024 | -59.73% |
April 16, 2024 | 58.73% |
April 15, 2024 | 58.73% |
April 12, 2024 | -37.50% |
April 11, 2024 | -45.95% |
April 10, 2024 | -45.95% |
April 09, 2024 | -25.00% |
April 08, 2024 | -25.00% |
April 05, 2024 | -25.00% |
April 04, 2024 | -25.00% |
April 03, 2024 | -67.74% |
April 02, 2024 | -33.33% |
April 01, 2024 | -22.22% |
March 28, 2024 | -56.25% |
March 27, 2024 | -53.75% |
Date | Value |
---|---|
March 26, 2024 | -53.75% |
March 25, 2024 | -56.25% |
March 22, 2024 | -39.56% |
March 21, 2024 | -24.14% |
March 20, 2024 | -31.25% |
March 19, 2024 | -31.25% |
March 18, 2024 | -31.25% |
March 15, 2024 | -31.25% |
March 14, 2024 | -53.75% |
March 13, 2024 | -18.75% |
March 12, 2024 | -53.12% |
March 11, 2024 | -53.12% |
March 08, 2024 | -6.88% |
March 07, 2024 | 25.00% |
March 06, 2024 | 16.25% |
March 05, 2024 | 16.25% |
March 04, 2024 | 16.25% |
March 01, 2024 | 16.25% |
February 29, 2024 | 16.25% |
February 28, 2024 | 16.25% |
February 27, 2024 | 238.2% |
February 26, 2024 | 24.00% |
February 23, 2024 | 24.00% |
February 22, 2024 | 24.00% |
February 21, 2024 | -6.53% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-94.40%
Minimum
Dec 28 2022
2.23K%
Maximum
Jan 04 2021
28.67%
Average
-29.03%
Median
Jul 10 2019
1 Year Total Returns (Daily) Benchmarks
Acasti Pharma Inc | 4.03% |
Aurinia Pharmaceuticals Inc | -53.57% |
Edesa Biotech Inc | -43.71% |
Lexaria Bioscience Corp | 86.83% |
Xenon Pharmaceuticals Inc | 6.25% |